{"schema_version":"secwatch.filing_event.v1","accession":"0001516551-22-000018","form_type":"8-K","ticker":"SKYE","cik":"0001516551","company_name":"Skye Bioscience, Inc.","filed_at":"2022-07-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:55.993101+00:00","generated_at":"2026-06-24T09:57:49.007170+00:00","sec_items":["1.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Skye Bioscience extends merger Outside Date with Emerald Health to Oct 15, 2022; adjusts meeting timeline for SEC review","bullets":["Outside Date extended to October 15, 2022; auto-extends to Nov 15 if SEC reviews proxy statement.","Shareholder meeting must be held by Oct 4 (no SEC review), Nov 4 (SEC review), or Nov 14 (amendments required).","Second amendment to Arrangement Agreement dated May 11, 2022; parties may further extend Outside Date by 45 days.","Extension conditioned on satisfaction of certain closing conditions and regulatory approvals not yet obtained."],"urls":{"canonical":"https://secwatch.observer/filing/0001516551-22-000018","json":"https://secwatch.observer/filing/0001516551-22-000018.json","markdown":"https://secwatch.observer/filing/0001516551-22-000018.md","text":"https://secwatch.observer/filing/0001516551-22-000018.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1516551/000151655122000018/0001516551-22-000018-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1516551/000151655122000018/skye-20220715.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T09:57:49.007170+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}